Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gin Hwa BiotechROCO:7806 22 Forward Dividend Yield % is 1.62% as of Jul. 22, 2026. GuruFocus rates ROCO:7806 with a GF Score™ of 22/100. The stock has 2 warning signs investors should review. Among 149 Biotechnology companies, Gin Hwa Biotech ranks better than 57.72% on this metric.
As of today (2026-07-22), the Forward Annual Dividend Yield of Gin Hwa Biotech is 1.62%.
As of today (2026-07-22), the Trailing Annual Dividend Yield of Gin Hwa Biotech is 1.60%.
ROCO:7806's Forward Dividend Yield % is ranked better than 57.72% of 149
companies
in the Biotechnology industry
Industry Median: 1.34
vs ROCO:7806: 1.62
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Gin Hwa Biotech Forward Dividend Yield % Related Terms
ROCO:7806 vs VRTX, REGN, ALNY: Forward Dividend Yield % Comparison
For the Biotechnology subindustry, Gin Hwa Biotech's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gin Hwa Biotech Forward Dividend Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Gin Hwa Biotech's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Gin Hwa Biotech's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 1.62% mean?
Gin Hwa Biotech (ROCO:7806) has a Forward Dividend Yield % of 1.62% as of Jul. 22, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Gin Hwa Biotech and its competitors. According to the industry distribution chart, Gin Hwa Biotech ranks #63 out of 149 companies in the Biotechnology industry, placing it in the top 42.3%.
Is Gin Hwa Biotech's Forward Dividend Yield % too high?
Gin Hwa Biotech's current Forward Dividend Yield % is 1.62%. The Biotechnology industry median Forward Dividend Yield % is 1.34. Gin Hwa Biotech's value of 1.62% is 20.9% above this industry median. Based on the distribution chart, Gin Hwa Biotech ranks #63 out of 149 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Gin Hwa Biotech has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Gin Hwa Biotech's Forward Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Gin Hwa Biotech ranks #63 out of 149 companies for Forward Dividend Yield %. This puts Gin Hwa Biotech in the upper half of its industry. The industry median Forward Dividend Yield % is 1.34. Gin Hwa Biotech's value of 1.62% is 20.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Biotechnology company?
The median Forward Dividend Yield % among Biotechnology companies is 1.34, based on 149 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gin Hwa Biotech's current Forward Dividend Yield % of 1.62% is 20.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Gin Hwa Biotech and its competitors. For the Biotechnology industry, the median Forward Dividend Yield % is 1.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gin Hwa Biotech's current Forward Dividend Yield % is 1.62%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gin Hwa Biotech stock overvalued right now?
Gin Hwa Biotech (ROCO:7806) has a current Forward Dividend Yield % of 1.62%. The current Forward Dividend Yield % is 1.62% and 20.9% above the Biotechnology industry median of 1.34. Gin Hwa Biotech's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Gin Hwa Biotech (ROCO:7806), the current Forward Dividend Yield % is 1.62% as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Gin Hwa Biotech Inc is engaged in developing completely original products to achieve every vision. Its Services and technology are Product Development, OEM Service, Core Technology, R & D Center, Professional Production, and Others.
22GF Score
Get the complete analysis for ROCO:7806
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7806 has been successfully added to your 
